Top coverage from the 2024 American Society of Clinical Oncology (ASCO) annual meeting included research topics in non-small ...
Roberto Salgado, MD, anatomic pathologist for breast cancer translational research at Institut Jules Bordet, examines the significance of tumor-infiltrating lymphocytes (TILs) in various breast cancer ...
Ian Neeland, MD, discusses the CINEMA program's impact on addressing social determinants of health (SDOH) in Ohio and the ...
The approval was based on the results of the SURMOUNT-OSA trial, which found patients had fewer breathing disruptions.
The FDA granted approval to Steqeyma (ustekinumab-stba) for inflammatory conditions, making it the seventh biosimilar to ...
Septal circumferential strain (Ecc) was significantly decreased in LGE-negative boys with Duchenne muscular dystrophy (DMD) ...
Our top content from the 100th annual American Heart Association (AHA) Scientific Sessions included exclusive expert insights ...
The FDA rejected sotagliflozin for type 1 diabetes and CKD. Lexicon will focus on LX9211 for diabetic neuropathic pain, with ...
Dan Bloomfield, MD, chief medical officer, Anthos, walks through promising findings demonstrating the efficacy of abelacimab, ...
Key findings from 2024 focused on conditions like vaccine-induced immune thrombotic thrombocytopenia, immune thrombocytopenia ...
Our top content for the year highlight many challenges the field of non–small cell lung cancer (NSCLC) encountered, with data ...
The top 5 podcasts for 2024 cover Medicare Advantage prior authorization, health equity, global immunization challenges, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback